Needham analyst has initiated coverage on Absci Corporation (NASDAQ:ABSI), a drug and target discovery company that harnesses ...

"In our view, the ability to generate high quality wet-lab data is critical for advancement," analyst says in initiating ...

ABS-101 appears to be ABSI’s main drug candidate for IBD. However, ABS-201 for hair loss and ABS-301 for solid tumors offer additional sizeable TAMs if successful. ABSI’s AI models and wet lab ...

(RTTNews) - Absci Corporation (ABSI), a Washington-based biotechnology company, Wednesday has announced a strategic collaboration with AMD to deploy AMD Instinct accelerators and ROCm software to ...

In this article, we are going to take a look at where Absci Corporation (NASDAQ:ABSI) stands against the other best biotech penny stocks to invest in now. Goldman Sachs has spotlighted an often ...

Needham has recently initiated Absci Corp (ABSI) stock to Buy rating, as announced on Today, according to Finviz. Earlier, on October 2, 2024, Guggenheim had initiated the stock to Buy, setting a ...

The rapid growth of artificial intelligence/machine learning (AI/ML ... aligning well with its AI/ML-driven platform. Price Action: ABSI stock is up 23% at $3.96 at the last check on Wednesday.

The firm increased its portfolio allocation in ABSI by 45.17% over the last quarter. Fred Alger Management holds 7,567K shares representing 6.59% ownership of the company. In its prior filing ...